CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
In a groundbreaking study published in Nucleic Acids Research, scientists at The University of Texas MD Anderson Cancer Center have ...
In a groundbreaking study published in the prestigious journal Cell Death Discovery, researchers Xu, Wang, Zhang, and colleagues have unveiled ...
For decades, histone deacetylase (HDAC) inhibitors have been heralded as promising cancer therapeutics due to their ability to block HDAC ...
In a groundbreaking study poised to redefine our understanding of tumor biology, researchers have unveiled a novel molecular axis that ...
In recent years, extrachromosomal DNA (ecDNA) has surged to the forefront of cancer biology, emerging as a pivotal factor driving ...
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center has announced a significant expansion of ...
A groundbreaking discovery from Cold Spring Harbor Laboratory (CSHL) promises to reshape the therapeutic landscape for estrogen receptor-positive (ER+) breast ...
The text provides a comprehensive overview of the role of BRPF1 (bromodomain and PHD finger-containing protein 1) in various gastrointestinal ...
Recent research led by Tono et al. sheds light on the complex interplay between chromatin remodeling and cancer with a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine